| Drug Name |
Desvenlafaxine succinate |
| Drug ID |
BADD_D00622 |
| Description |
Desvenlafaxine (O-desmethylvenlafaxine) the major active metabolite of venlafaxine, is an antidepressant from the serotonin norepinephrine reuptake inhibitor (SNRI) class[Label]. Desvenlafaxine may be used to treat major depressive disorder[Label]. It is formulated as an extended release tablet[Label]. Desvenlafaxine was approved by the FDA in 2008[L6016]. |
| Indications and Usage |
Desvenlafaxine is indicated for the treatment of major depressive disorder in adults[A6990,A6991,Label]. |
| Marketing Status |
approved; investigational |
| ATC Code |
N06AX23 |
| DrugBank ID |
DB06700
|
| KEGG ID |
D02570; D11619
|
| MeSH ID |
D000069468
|
| PubChem ID |
9800068
|
| TTD Drug ID |
D0O3FG
|
| NDC Product Code |
16436-0087; 59762-1211; 63629-7559; 68180-593; 68180-604; 68788-7175; 71335-2130; 46708-541; 71335-1331; 59762-1222; 71205-586; 24196-162; 66651-928; 71335-1150; 72189-147; 42816-1211; 46708-542; 0008-1211; 68788-7194; 14501-0065; 42816-1210; 42816-1222; 65841-173; 68724-1236; 69766-008; 0008-1210; 51991-006; 68071-2704; 68180-592; 65977-0142; 0008-1222; 46708-540; 51991-312; 59762-1210; 63629-7525; 53296-0087; 50090-5274; 14778-0606; 51991-311 |
| UNII |
ZB22ENF0XR
|
| Synonyms |
Desvenlafaxine Succinate | Succinate, Desvenlafaxine | O-desmethylvenlafaxine Succinate Monohydrate | Monohydrate, O-desmethylvenlafaxine Succinate | O desmethylvenlafaxine Succinate Monohydrate | Succinate Monohydrate, O-desmethylvenlafaxine | 2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate | O-desmethylvenlafaxine Succinate | O desmethylvenlafaxine Succinate | Succinate, O-desmethylvenlafaxine | WY 45,233 | 45,233, WY | WY-45,233 | WY45,233 | WY-45233 | WY45233 | WY 45233 | 45233, WY | Pristiq | Desvenlafaxine | O-desmethylvenlafaxine | O desmethylvenlafaxine | 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol |
